GenScript ProBio is based in Nanjing, China. It has raised $240M in total funding. Latest round: Series C.
GenScript ProBio is based in Nanjing, China. GenScript ProBio has raised $240M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in April 2023. The round record for GenScript ProBio runs through 2023; nothing later has been disclosed. Investors on record include Legend Capital, China Merchants Capital, New Alliance Capital, Highlight Capital, C&D no.7 Holdings, CTSII Fund. 6 distinct backers are named across the disclosed rounds.
Every GenScript ProBio figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Nanjing at a similar stage.
1 disclosed round on record.
Company funding database · Investor directory · Founder database · Mega-rounds 2026